Researchers at Cedars-Sinai have made an important discovery that could change the lives of some people diagnosed with a type ...

The U.S. Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

The new test, known as the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, detects amyloid plaques through blood testing, a ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

Four of five Americans surveyed want to know if they face a future with Alzheimer's disease before symptoms arise, according ...

According to the Alzheimer’s Association: “An estimated 7.2 million Americans age 65 and older are living with Alzheimer’s ...

The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...

New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.

As part of an eight-year trial, CMS is partnering with Right at Home, an in-home care and assistance agency in Beachwood, ...

Scientists discovered protein changes tied to frontotemporal dementia, offering hope for earlier detection and personalized ...

After her mom's diagnosis of Lewy body dementia, a Lincoln woman said she noticed there was a lack of culturally diverse support options in Nebraska. Now, she's working to raise awareness and be part ...